Eversept Partners’s Albireo Pharma Inc ALBO Stock Holding History

Eversept Partners’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-78,029	Closed	-$2.07M	–	72
2020 Q2	$2.07M	Hold	78,029	–	–	0.28%	49
2020 Q1	$1.28M	Hold	78,029	–	–	0.32%	36
2019 Q4	$1.98M	Buy	78,029 +60,000	+333%	+$1.2M	0.35%	50
2019 Q3	$361K	Hold	18,029	–	–	0.11%	54
2019 Q2	$581K	Hold	18,029	–	–	0.16%	55
2019 Q1	$581K	Hold	18,029	–	–	0.17%	44
2018 Q4	$442K	Hold	18,029	–	–	0.24%	44
2018 Q3	$594K	Hold	18,029	–	–	0.26%	49
2018 Q2	$640K	Hold	18,029	–	–	0.29%	52
2018 Q1	$587K	Buy	+18,029	New	+$607K	0.27%	48

Other funds holding ALBO

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Eversept Partners's ALBO Position: Q3 2020 in Review

Eversept Partners sold out of Albireo Pharma Inc (ALBO) in Q3 2020, closing a stake of 78,029 shares — an estimated $2.07M sold.

Eversept Partners first reported a position in ALBO in Q1 2018 and held it in 10 quarters. The position peaked at $2.07M in Q2 2020. 108 funds tracked by Wall St. Rank hold ALBO as of Q3 2020.

Eversept Partners reported no remaining Albireo Pharma Inc position as of Q3 2020 after selling out during the quarter.
Eversept Partners sold 78,029 Albireo Pharma Inc shares in Q3 2020, an estimated $2.07M.
Eversept Partners first reported a position in Albireo Pharma Inc in Q1 2018 and held it in 10 quarters.
Eversept Partners's Albireo Pharma Inc position peaked at $2.07M in Q2 2020.
108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2020.

Based on Eversept Partners's 13F filing for Q3 2020, filed 12 Nov 2020.